DeCODE Genetics
Reykjavík
About DeCODE Genetics
DeCODE Genetics is a biopharmaceutical company that develops and offers diagnostic tests for variants in genes. DeCODE was established to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. The company has discovered key genetic risk factors for many common diseases ranging from cardiovascular disease to cancer. DeCODE Genetics was founded in 1996 and is based in Reykjavik, Iceland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Funding stage: M&A
- Last round: Seed (Jan 1998)
- Ticker: nasdaq:DCGN
- Website: decode.com
- Phone: +354 570 1900
Industries & Categories
Biotechnology, Genetics, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/decode-genetics-258255 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.